Financial statements Bioperm
Balance sheet data of BIOPERM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 182 653,78 | 263 346,23 | 251 236,88 | 684 792,85 | 716 880,62 | 881 967,83 |
A. Fixed assets | - | 66 456,74 | 73 574,35 | 70 209,40 | 63 690,16 | 57 170,92 |
B. Current assets | 182 653,78 | 196 889,49 | 177 662,53 | 614 583,45 | 653 190,46 | 824 796,91 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 182 653,78 | 263 346,23 | 251 236,88 | 684 792,85 | 716 880,62 | 881 967,83 |
A. Equity | 159 983,99 | 199 825,76 | 187 865,98 | 461 468,22 | 338 463,02 | 206 870,67 |
B. Liabilities and provisions for liabilities | 22 669,79 | 63 520,47 | 63 370,90 | 223 324,63 | 378 417,60 | 675 097,16 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | 22 669,79 | 63 520,47 | 59 305,86 | 202 999,43 | 358 092,40 | 654 771,96 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.